Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess whether the sequence in which anthracyclines and taxanes are administered, in an adjuvant or neoadjuvant setting, affects outcomes in women with early breast cancer.